Literature DB >> 18423870

En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy.

J Fernando Arevalo1.   

Abstract

OBJECTIVE: En bloc perfluorodissection (EBPD) is a surgical dissection technique that facilitates removal of epiretinal membranes and the posterior hyaloid. It is carried out by injecting perfluorocarbon liquid between the retina and the posterior hyaloid to separate the epiretinal tissues from the subjacent retina. The objective of this study was to describe the technique and to demonstrate the applicability of using EBPD during vitrectomy in eyes with tractional retinal detachment (TRD) in proliferative diabetic retinopathy (PDR).
DESIGN: Prospective, interventional case series. PARTICIPANTS: Fifty-seven patients (eyes) with TRD in PDR participated in the study.
METHODS: The author performed EBPD in 57 eyes (consecutive patients) during vitrectomy for TRD in severe PDR. Mean age of the patients was 42 years (range, 23-84 years). Mean surgical time was 50 minutes (range, 40-75 minutes). The group of patients was followed up for a mean of 18 months (range, 8-26 months). MAIN OUTCOME MEASURES: Best-corrected visual acuity (BCVA), retinal status, and complications at the end of follow up.
RESULTS: None of the patients have developed ocular hypertension or undue inflammation, and anatomic success-accompanied by visual improvement (> or =2 Early Treatment Diabetic Retinopathy Study [ETDRS] lines) in 70.1% (40/57)-occurred in 100% (57/57) of eyes. In 14 eyes (24.5%), BCVA remained stable, and in 3 eyes (5.2%), BCVA decreased (> or =2 ETDRS lines). Final BCVA was 20/50 or better in 25%, between 20/60 and 20/400 in 47%, and worse than 20/400 in 28%. Complications included phthisis bulbi in 1 (1.7%) eye, iatrogenic retinal breaks in 4 (7%) eyes, vitreous hemorrhage requiring another procedure in 4 (7%) eyes, and cataract in 15 (26.3%) eyes.
CONCLUSIONS: This report demonstrates the applicability of using EBPD during vitrectomy in eyes with TRD in PDR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423870     DOI: 10.1016/j.ophtha.2008.02.008

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Perfluorocarbon in vitreoretinal surgery and preoperative bevacizumab in diabetic tractional retinal detachment.

Authors:  J Fernando Arevalo; Martin A Serrano; Juan D Arias
Journal:  World J Diabetes       Date:  2014-10-15

2.  Perfluorocarbon-perfused 23 gauge three-dimensional vitrectomy for complicated diabetic tractional retinal detachment.

Authors:  Raul Velez-Montoya; Jose Luis Guerrero-Naranjo; Gerardo Garcia-Aguirre; Virgilio Morales-Cantón; Jans Fromow-Guerra; Hugo Quiroz-Mercado
Journal:  Clin Ophthalmol       Date:  2011-12-20

Review 3.  Inflammation induced by perfluorocarbon liquid: intra- and postoperative use.

Authors:  Marta S Figueroa; Diego Ruiz Casas
Journal:  Biomed Res Int       Date:  2014-03-24       Impact factor: 3.411

Review 4.  Surgical management of diabetic retinopathy.

Authors:  Vishali Gupta; J Fernando Arevalo
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

5.  Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago's county health system.

Authors:  Jared T Sokol; Sidney A Schechet; Darin T Rosen; Kevin Ferenchak; Sherif Dawood; Dimitra Skondra
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.